within Pharmacolibrary.Drugs.ATC.A;

model A02AD04
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 8.333333333333334e-06,
    adminDuration  = 600,
    adminMass      = 500 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.003,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>A02AD04</td></tr><td>route:</td><td>orally</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Hydrotalcite is an inorganic compound used as an antacid to neutralize stomach acid. It is primarily used for the symptomatic relief of heartburn and gastric hyperacidity. Hydrotalcite is available over-the-counter in some countries and is not classified as an essential medicine, but it remains in use in several regions for dyspepsia and related conditions.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for healthy adults, as no published detailed pharmacokinetic studies could be identified.</p><h4>References</h4><ol><li><p>Choi, G, et al., &amp; Choy, JH (2021). Hydrotalcite-Niclosamide Nanohybrid as Oral Formulation towards SARS-CoV-2 Viral Infections. <i>Pharmaceuticals (Basel, Switzerland)</i> 14(5) –. DOI:<a href=\"https://doi.org/10.3390/ph14050486\">10.3390/ph14050486</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/34069716/\">https://pubmed.ncbi.nlm.nih.gov/34069716</a></p></li><li><p>Calarco, A, et al., &amp; Peluso, G (2015). Long-Term Fluoride Release from Dental Resins Affects STRO-1+ Cell Behavior. <i>Journal of dental research</i> 94(8) 1099–1105. DOI:<a href=\"https://doi.org/10.1177/0022034515584615\">10.1177/0022034515584615</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/25924857/\">https://pubmed.ncbi.nlm.nih.gov/25924857</a></p></li><li><p>Perioli, L, et al., &amp; Rossi, C (2007). Mucoadhesive bilayered tablets for buccal sustained release of flurbiprofen. <i>AAPS PharmSciTech</i> 8(3) E54–None. DOI:<a href=\"https://doi.org/10.1208/pt0803054\">10.1208/pt0803054</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/17915804/\">https://pubmed.ncbi.nlm.nih.gov/17915804</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end A02AD04;
